(Alliance News) - AstraZeneca PLC on Monday said one of its treatments has been approved in the US for treating adults with unresectable liver cancer. Read More
(Alliance News) - AstraZeneca PLC on Thursday said that new analyses from a phase 3 treatment trial show the potential of its Covid drug Evusheld to reduce severity and mortality. Read More
(Alliance News) - Stock prices in London closed in the red on Wednesday, as discouraging economic data and mixed signals from the UK's central bank weighed on investor sentiment. Read More
(Alliance News) - AstraZeneca PLC on Wednesday said its subsidiary Alexion Pharmaceuticals Inc, which focuses on rare diseases, will publish "new data showing significant advances" regarding the treatment for a form of neuromyelitis with its drug Ultomiris. Read More
(Alliance News) - Illumina Inc on Tuesday said it is collaborating with AstraZeneca PLC on drug target discovery, with a focus on artificial intelligence-based research on genes. Read More
(Alliance News) - AstraZeneca PLC on Tuesday said its Tezspire and Koselugo drugs have been approved in Japan for the treatment of severe asthma and patients that suffer from a rare genetic condition, respectively. Read More
(Alliance News) - AstraZeneca PLC on Friday said its Ultomiris drug has been approved in the EU to treat myasthenia gravis, a condition which causes muscle weakness. Read More
(Alliance News) - European markets are set to end a difficult week in decent fashion on Friday, as investors take onboard a series of hawkish central bank moves. Read More
(Alliance News) - AstraZeneca PLC on Thursday, along with pharmaceutical peer Merck & Co Inc, said that Lynparza has been approved in China for the maintenance treatment of adults with advanced epithelial ovarian, fallopian tube or primary peritoneal cancer. Read More
(Alliance News) - Stocks in London are set to open lower on Thursday, ahead of a major interest rate decision by the Bank of England and a day after the US Federal Reserve settled for another three-quarter-point rate hike. Read More
(Alliance News) - Stocks in London are set to open unchanged on Wednesday ahead the US Federal Reserve's interest rate decision later in the day and the Bank of England's decision on Thursday. Read More
(Alliance News) - Stocks in London are set to open higher on Tuesday, as markets in London return to action following a bank holiday for the state funeral of Queen Elizabeth II. Read More
(Alliance News) - The mood remained downbeat at the end of a sour week for global equities, after data dashed hopes that US inflation is easing fast enough to warrant less aggressive interest rate hikes by the Federal Reserve. Read More
(Alliance News) - AstraZeneca PLC on Friday said it received two recommendations for drug approvals in the EU, while a drug for blood disorder paroxysmal nocturnal haemoglobinuria met its primary endpoint in a phase three trial. Read More
